LORAZEPAM RELATED COMPOUND D (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLIC ACID)
Synonym(s):6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic acid
- CAS NO.：54643-79-7
- Empirical Formula: C15H8Cl2N2O2
- Molecular Weight: 319.14
- MDL number: MFCD06203519
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-05-28 06:15:18
What is LORAZEPAM RELATED COMPOUND D (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLIC ACID)?
Chemical properties
Off-White Solid
The Uses of LORAZEPAM RELATED COMPOUND D (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLIC ACID)
6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic Acid is a metabolite of Lorazepam (L469850).
The Uses of LORAZEPAM RELATED COMPOUND D (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLIC ACID)
6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic Acid (Lorazepam Related Compound D) is a metabolite of Lorazepam (L469850).
Properties of LORAZEPAM RELATED COMPOUND D (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLIC ACID)
| Melting point: | 218-219 °C (decomp) |
| Boiling point: | 534.7±60.0 °C(Predicted) |
| Density | 1.507±0.06 g/cm3(Predicted) |
| solubility | DMSO (Slightly, Heated), Methanol (Slightly, Heated) |
| form | neat |
| pka | 3.66±0.50(Predicted) |
| BRN | 816764 |
| Stability: | Hygroscopic |
Safety information for LORAZEPAM RELATED COMPOUND D (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLIC ACID)
| Signal word | Warning |
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H319:Serious eye damage/eye irritation H413:Hazardous to the aquatic environment, long-term hazard |
| Precautionary Statement Codes |
P273:Avoid release to the environment. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for LORAZEPAM RELATED COMPOUND D (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLIC ACID)
LORAZEPAM RELATED COMPOUND D (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLIC ACID) manufacturer
GLP Pharma Standards
4Y
Phone:+91-7893074638
Whatsapp: +91-7893074638
product: Lorazepam Related Compound-D 54643-79-7 NLT 95%
New Products
9-Mesityl-10-methylacridinium perchlorate Sulfapyridine Fmoc-OSu (R)-(-)-2-Amino-1-propanol Cyclobutanone 5-bromo-4-fluoro-2-nitrobenzaldehyde 4 pentyn 1 ol N-Vinylformamide Phenethyl cinnamate Pyrrolo[1,2-a]pyrimidine-6-carboxylic acid, 4,6,7,8-tetrahydro-4-oxo-, sodium salt (1:1), (6S) Ethyl 3-phenylpropanoate β-Bromostyrene Methacrylate-PEG-Methacrylate, Mn:35000 2,4-Dihydroxyacetophenone 2-Chloro 5-Fluoro Pyridine Vasicinone 2-Chloroisonicotinic Acid Tween 80 or Polysorbate 80 5-Bromo-1-Pentyne 1-(2-Methyl-5-nitrophenyl)guanidine Nitrate Methyl trans-4-Aminocyclohexanecarboxylate Hydrochloride 2-Pentyn-1-oL 4-Nitrobenzotrifluoride N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamideRelated products of tetrahydrofuran
![1-[[2-(4-Chlorophenyl)ethyl]amino]-2-chloropropane](https://img.chemicalbook.in/CAS/GIF/953789-37-2.gif)
You may like
-
Lorazepam Related Compound-D 54643-79-7 NLT 95%View Details
54643-79-7 -
1191-95-3 Cyclobutanone 98+View Details
1191-95-3 -
Fmoc-OSu 98+View Details
82911-69-1 -
(R)-(-)-2-Amino-1-propanol 35320-23-1 98+View Details
35320-23-1 -
1191-95-3 Cyclobutanone 98+View Details
1191-95-3 -
213382-45-7 98+View Details
213382-45-7 -
Fmoc-OSu 98+View Details
82911-69-1 -
(R)-(-)-2-Amino-1-propanol 35320-23-1 98+View Details
35320-23-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.